Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Centene Corp (NY: CNC )

74.39 -2.94 (-3.80%)
Streaming Delayed Price Updated: 3:54 PM EDT, May 24, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Centene Corp

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
What 9 Analyst Ratings Have To Say About Centene
Over the past 3 months, 9 analysts have published their opinion on Centene (NYSE:... 
Via Benzinga
CNC: This Leading Healthcare Stock Is Getting Attractive
The next major support level for Centene Corp's stock will be around the $59.00 area. This support level is where the stock was defended in late April 2021 before surging to its July 2021 top. 
Via Talk Markets
10 Health Care Stocks Showing Unusual Options Activity In Today's Session
This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges... 
Via Benzinga
Centene Corporation (CNC) Q2 2021 Earnings Call Transcript
CNC earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Centene Reports Mixed Bag On Q2 Earnings, Raises FY2021 Sales Outlook
Centene Corporation (NYSE: CNC) reported Q2 adjusted EPS of $1.25, missing the consensus estimate of $1.39 and lower than $2.40 reported a year ago. Sales for the... 
Via Benzinga
Earnings Scheduled For July 27, 2021
Companies Reporting Before The Bell • Navios Maritime Partners (NYSE:NMM) is projected to report quarterly earnings at $2.93 per share on revenue of $146.03 million.... 
Via Benzinga
What 10 Analyst Ratings Have To Say About Centene
Within the last quarter, Centene (NYSE:CNC) has observed the... 
Via Benzinga
Where Centene Stands With Analysts
Analysts have provided the following ratings for Centene (NYSE:CN... 
Via Benzinga
Earnings Scheduled For October 26, 2021
Companies Reporting Before The Bell • Veoneer (NYSE:VNE) is likely to report quarterly loss at $0.83 per share on revenue of $408.69 million. • Aarons (NYSE:AAN)... 
Via Benzinga
Thoughts For Thursday: Markets Higher And Halloween Closer
Via Talk Markets
Why Centene Shares Are Rising
Shares of healthcare providers and insurers, including Centene Corp (NYSE: CNC) are trading higher in sympathy with Anthem, which gained after reporting better-than-expected... 
Via Benzinga
A Bearish Sign Appears On Centene's Chart
If history is any guide, there may be trouble ahead for shares of Centene(NYSE:CNC). A so-called "death cross" has formed on its chart and, not surprisingly, this could be... 
Via Benzinga
Cramer Weighs In On Joby Aviation, Pitney Bowes And More
On CNBC's "Mad Money Lightning Round," Jim Cramer said Celularity Inc (NASDAQ: CELU) is interesting. Nobody likes it, but if you buy it here, you might get really... 
Via Benzinga
Analyst Ratings For Centene
Over the past 3 months, 10 analysts have published their opinion on Centene (NYSE:... 
Via Benzinga
Analyst Ratings For Centene
Centene (NYSE:CNC) has observed the following analyst ratings within the last... 
Via Benzinga
Analyst Ratings For Centene
Analysts have provided the following ratings for Centene (NYSE:C... 
Via Benzinga
Where Centene Stands With Analysts
Within the last quarter, Centene (NYSE:CNC) has observed the following analys... 
Via Benzinga
Understanding Centene's Unusual Options Activity
Shares of Centene (NYSE:CNC) saw some unusual options activi... 
Via Benzinga
Centene: Q2 Earnings Insights
Shares of Centene (NYSE:CNC) were unchanged after the company reported Q2 results. Quarterly Results Earnings per share decreased 47.92% over the past year to $1.25, which... 
Via Benzinga
The Daily Biotech Pulse: ScPharma's Positive Data, Lilly Goes Shopping, LeMaitre Pre-Announces Q2 Revenues
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 13) Biohaven Pharmaceutical... 
Via Benzinga
Biogen's Costly Alzheimer's Treatment May Face Restricted Medicare Access: WSJ
The recent approval of Biogen Inc's (NASDAQ: BIIB) high-price Alzheimer's drug is raising questions about who will have access to the $56,000/year... 
Via Benzinga
Clover Health Stock Scores Relative Strength Rating Upgrade; Joins Meme Stock Club
When building a watch list, focus on stocks with an 80-plus RS Rating. Clover Health stock just cleared that benchmark with an upgrade to 80. 
Via Investor's Business Daily
10 Biggest Price Target Changes For Thursday
Piper Sandler raised Patterson Companies, Inc. (NASDAQ: PDCO) price target from $34 to $44. Patterson Companies shares rose 4% to $36.82 in pre-market trading. TD Securities... 
Via Benzinga
Pete Najarian Sees Unusual Options Activity In Intel And Centene
On CNBC's "Fast Money Halftime Report," Pete Najarian said that he bought calls in Intel Corporation (NASDAQ: INTC) on Tuesday. He noticed during the first half of... 
Via Benzinga
Centene To Pay $143.3M To Settle Ohio, Mississippi Suit Over Double-Billing On Medicaid Drugs
Centene Corporation (NYSE: CNC) has agreed to pay Ohio $88.3 million to settle a lawsuit accusing the company of making off with millions of dollars meant to help... 
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
Meme Stock Clover Health Sees Huge Relative Strength Rating Bump
An RS Rating upgrade for "meme" stock Clover Health shows its improving technical performance, despite a roller-coaster trip on the market. 
Via Investor's Business Daily
Why Centene Stock Was Up 19% in May
New executives and confirmation that an acquisition will close soon sparked a rally in the shares. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For May 19, 2021
Upgrades For Agilysys Inc (NASDAQ:AGYS), Craig-Hallum upgraded the previous rating of Hold to Buy. Agilysys earned $0.21 in the fourth quarter, compared to $0.05 in the... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 11, 2021
Upgrades For CEVA Inc (NASDAQ:CEVA), Barclays upgraded the previous rating of Equal-Weight to Overweight. For the first quarter, CEVA had an EPS of $0.01, compared to year... 
Via Benzinga
Dow Gives Back Gains Amid Profit-Taking Spree
The major benchmarks are modestly higher this afternoon, as investors move to take profits following blowout earnings reports from Apple and Facebook. 
Via Talk Markets
Topics Stocks
Exposures US Equities
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.